Title:
Team Grant: Netherlands-Canada Type 2 Diabetes Research Consortium
Agreement Value:
$1,999,784.00
Agreement Date:
Jan 1, 2021 - Dec 31, 2025
Description:
The specific objectives of this funding opportunity are:
• to support research and development with a considerable economic and societal impact that:
- focuses on prevention, reversal or remission of type 2 diabetes or pre-diabetes;
- improves the quality of life for individuals with type 2 diabetes and their families;
- leads to sustainable collaborations between Dutch and Canadian type 2 diabetes researchers and Canadian type 2 diabetes researchers and for-profit private parties and other private parties.
Organization:
Canadian Institutes of Health Research
Expected Results:
This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.
Location:
Sherbrooke, Quebec, CA J1K 2R1
Reference Number:
236-2020-2021-Q4-00052
Report Type:
Grants and Contributions
Recipient Type:
Individual or sole proprietorship
Recipient's Legal Name:
Carpentier, André C
Research Organization:
Université de Sherbrooke
Program:
Research in Priority Areas
Program Purpose:
This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.